England - London • TMT (technology, media and telecoms)
3

PATMA: Patent attorneys

Greaves Brewster LLP

Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :

Beck Greener LLP logo
Beck Greener LLP
Swindell & Pearson Ltd logo
Swindell & Pearson Ltd
Reddie & Grose LLP logo
Reddie & Grose LLP
Greaves Brewster LLP boasts attorneys spread across the UK in Cheddar, London, Cardiff, Nottingham, and Bristol, all of whom handle the preparation, filing, prosecution, and management of patent applications and portfolios. Another key area of activity for the group is representation in opposition and appeal proceedings before the EPO, working with a client base comprising a variety of companies from the life sciences, chemistry, engineering, and physics sectors. Medical device technology is a particular area of strength for Rachel Wallis, in addition to her expertise in the life sciences sector, while Jakob Bumke is notable in the chemistry and engineering industry. Antibody and vaccine technology are key areas of expertise for David Spinner.
L’éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘The patent attorney team at Greaves Brewster offers excellent quality of attorneys with deep industry knowledge and bench strength. They are very personable, commercial and provide excellent client care. They leverage use of technology efficiently. I have collaborated with them on multiple matters for clients and they never disappoint.’

  • ‘Rachel Wallis is critical to the continuing success and growth of Greaves Brewster. She ensures consistency of client management, quality of work product and approach across both the patent and trade mark practices. I consider her a key trusted adviser. Her attention to client care and commercial astuteness is one of the reasons why I go back to her again and again.'

Clients clés

  • Sigma-Aldrich Co. LLC
  • P2i Ltd

Points forts

  • Advised Merus N.V. on its PCT applications into national and regional phases in over 65 countries and regions and subsequent prosecution in a multi-billion-dollar market.
  • Assisted Theragnostics Limited and Ariceum Therapeutics GmbH with a high-value patent application in the US to ensure a grant which, through associated licensing, triggered significant royalty payments to the client.